MARKET

PBMWW

PBMWW

PSYENCE BIOMEDICAL LTD
NASDAQ
0.0198
+0.0019
+10.61%
Closed 12:48 01/07 EST
OPEN
0.0169
PREV CLOSE
0.0179
HIGH
0.0198
LOW
0.0159
VOLUME
9.06K
TURNOVER
--
52 WEEK HIGH
0.0411
52 WEEK LOW
0.0100
MARKET CAP
--
P/E (TTM)
-0.0389
1D
5D
1M
3M
1Y
5Y
1D
Psyence BioMed Appoints Graham Patrick to Board as Christopher Bull Resigns
Reuters · 2d ago
Weekly Report: what happened at PBMWW last week (1229-0102)?
Weekly Report · 2d ago
Weekly Report: what happened at PBMWW last week (1222-1226)?
Weekly Report · 12/29/2025 09:14
Weekly Report: what happened at PBMWW last week (1215-1219)?
Weekly Report · 12/22/2025 09:14
Psyence BioMed Wins Ethics Approval for PsyLabs Psilocybin in Phase IIb Cancer Trial
Reuters · 12/19/2025 12:00
PSYENCE BIOMED ANNOUNCES APPROVAL FOR USE OF PSYLABS’ PSILOCYBIN PRODUCT IN PHASE IIB CLINICAL TRIAL
Reuters · 12/19/2025 12:00
PSYENCE BIOMEDICAL LTD: STUDY REMAINS ON TRACK TO DELIVER TOP-LINE RESULTS IN 2026
Reuters · 12/19/2025 12:00
Weekly Report: what happened at PBMWW last week (1208-1212)?
Weekly Report · 12/15/2025 09:15
More
About PBMWW
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBMWW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBMWW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBMWW stock methods without spending real money on the virtual paper trading platform.